International Clinical Trial: A phase Ia/Ib study OF STA551 as a single agent and in combination with atezolizumab in patients with solid tumors

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ISRCTN16821696) titled 'A phase Ia/Ib study OF STA551 as a single agent and in combination with atezolizumab in patients with solid tumors' on June 12.

Study Type: Interventional

Study Design: Allocation: N/A: single arm study Masking: Open (masking not used) Control: Uncontrolled Assignment: Single Purpose: Treatment

Primary Sponsor: Chugai Pharmaceutical Co., Ltd. (Japan)

Condition: Locally advanced or metastatic solid tumors Cancer

Intervention: This clinical trial includes three groups (Stages) as follows

Recruitment Status: Not Recruiting

Phase: Phase I

Date of First Enrollment: 11/03/2020

Target Sample Size: 233

Cou...